Key facts
- This page summarizes Ph.D. Daniel Billen's Form 4 filing for Aurinia Pharmaceuticals Inc. (AUPH).
- 5 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 23 May 2023, 17:17.
Ph.D. Daniel Billen - 18 May 2023 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)
- Reporting relationship
- Director
- Issuer ticker
- AUPH
- Reported as of
- 18 May 2023
- Net transaction value
- -$52,359
- SEC form
- 4
- Accepted by SEC
- 23 May 2023, 17:17:48 UTC
- Prior SEC filing
- 20 May 2022
- Next SEC filing
- 22 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Daniel Billen, Ph.D.
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ph.D. Daniel Billen filed Form 4 for Aurinia Pharmaceuticals Inc. (AUPH) on 23 May 2023.
Change
- Previous filing in this sequence was filed on 20 May 2022.
- Current net transaction value: -$52,359.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AUPH
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +8,733
- Change %
- +44%
- Price
- Shares after
- 28,733
- Date
- 18 May 2023
- Ownership
- Direct
- Footnotes
- F1
AUPH
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +9,310
- Change %
- +32%
- Price
- $0.000000
- Shares after
- 38,043
- Date
- 19 May 2023
- Ownership
- Direct
- Footnotes
- F2
AUPH
transaction
Common Stock
Sale
- Transaction value
- $52,359
- Shares
- -4,650
- Change %
- -12%
- Price
- $11.26
- Shares after
- 33,393
- Date
- 23 May 2023
- Ownership
- Direct
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AUPH
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -8,733
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 18 May 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,733
- Exercise price
- Footnotes
- F1
AUPH
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +15,234
- Change %
- Price
- $0.000000
- Shares after
- 15,234
- Date
- 19 May 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,234
- Exercise price
- $10.74
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date.
Footnote F2
Represents grant of the RSUs payable solely in common stock of the Issuer. The shares subject to the RSUs shall vest one year from date of grant.
Footnote F3
Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs.
Footnote F4
The option vests in twelve equal monthly installments commencing on June 19, 2023.